Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3285010 | Clinical Gastroenterology and Hepatology | 2010 | 8 Pages |
Abstract
Citalopram was not superior to placebo in treating non-depressed IBS patients. Changes in symptoms were not substantially correlated with changes in rectal sensation assessed by barostat. Any benefit of citalopram in non-depressed IBS patients is likely to be modest at best.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Uri Ladabaum, Annie Sharabidze, Theodore R. Levin, Wei K. Zhao, Elaine Chung, Peter Bacchetti, Chengshi Jin, Barbara Grimes, Craig J. Pepin,